Suscribirse

Reduction of red blood cell transfusion with a patient blood management protocol in urological and visceral surgery: a before-after study - 07/07/24

Doi : 10.1016/j.accpm.2024.101395 
A. Godon a, , M. Dupuis a, S. Amdaa a, G. Pevet a, E. Girard b, G. Fiard c, D. Sourd d, JL. Bosson d, JF. Payen a, P. Albaladejo a, P. Bouzat a
a Univ. Grenoble Alpes, Department of Anaesthesia and Intensive Care, Grenoble Alpes University Hospital, Grenoble, France 
b Univ. Grenoble Alpes, Digestive and Emergency Surgery Unit, CNRS, TIMC, CHU Grenoble Alpes, 38000, Grenoble, France 
c Department of Urology, Grenoble Alpes University Hospital, Grenoble, France 
d Data-Stat Department, Grenoble Alpes University Hospital, Grenoble, France 

Corresponding author.

Abstract

Background

Although Patient Blood Management (PBM) is recommended by international guidelines, little evidence of its effectiveness exists in abdominal surgery. The aim of this study was to evaluate the benefits of the implementation of a PBM protocol on transfusion incidence and anaemia-related outcomes in major urological and visceral surgery.

Methods

In this before-after study, a three-pillar PBM protocol was implemented in 2020–2021 in a tertiary care centre, including preoperative correction of iron-deficiency anaemia, intraoperative tranexamic acid administration, and postoperative restrictive transfusion. A historical cohort (2019) was compared to a prospective cohort (2022) after the implementation of the PBM protocol. The primary outcome was the incidence of red blood cell transfusion intraoperatively or within 7 days after surgery.

Results

Data from 488 patients in the historical cohort were compared to 499 patients in the prospective cohort. Between 2019 and 2022, screening for iron deficiency increased from 13.9% to 69.8% (p < 0.01), tranexamic acid administration increased from 9.5% to 84.6% (p < 0.01), and median haemoglobin concentration before transfusion decreased from 77 g.L−1 to 71 g.L−1 (p = 0.02). The incidence of red blood cell transfusion decreased from 11.5% in 2019 to 6.6% in 2022 (relative risk 0.58, 95% CI 0.38−0.87, p = 0.01). The incidence of haemoglobin concentration lower than 100 g.L−1 at discharge was 24.2% in 2019 and 21.8% in 2022 (p =  0.41). The incidence of medical complications was comparable between the groups.

Conclusion

The implementation of a PBM protocol over a two-year period was associated with a reduction of transfusion in major urological and visceral surgery.

El texto completo de este artículo está disponible en PDF.

Keywords : Iron-deficiency anaemia, Patient blood management, Tranexamic acid, Transfusion, Urological surgery, Visceral surgery


Esquema


 The results of this study were presented as an oral presentation and an e-Poster during the French national congress of Anaesthesia and Intensive Care (SFAR) on the 20th September 2023 ("IMPACT D'UN PROTOCOLE DE GESTION DU CAPITAL SANGUIN EN CHIRURGIE UROLOGIQUE ET DIGESTIVE – ÉTUDE ASTEROIDE", communication n°217).


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 43 - N° 4

Artículo 101395- août 2024 Regresar al número
Artículo precedente Artículo precedente
  • Optimization of cerebral oxygenation based on regional cerebral oxygen saturation monitoring during carotid endarterectomy: a Phase III multicenter, double-blind randomized controlled trial
  • Yann Le Teurnier, Bertrand Rozec, Cecile Degryse, François Levy, Youcef Miliani, Gilles Godet, Georges Daccache, Cyrille Truc, Eric Steinmetz, Alexandre Ouattara, Bernard Cholley, Jean-Marc Malinovsky, Denis Portier, Gregory Dupont, Darius Liutkus, Pierre Viard, Morgane Pere, Benjamin Daumas-Duport, Pierre-Aubin Magras, Mickael Vourc’h, the EMOCAR Study Group
| Artículo siguiente Artículo siguiente
  • Obstetric units' preparedness to manage critically ill women. The second report from the MaCriCare study
  • Paweł Krawczyk, Dominika Dabrowska, Emilia Guasch, Henrik Jörnvall, Nuala Lucas, Frédéric J. Mercier, Alexandra Schyns-van den Berg, Carolyn F. Weiniger, Łukasz Balcerzak, Steve Cantellow, on behalf of the MaCriCare study group

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.